# Teva and Insilico partner on predictive biomanufacturing technology

Teva Pharmaceuticals and Insilico Biotechnology announced an agreement to apply Insilico's predictive biomanufacturing technology (Digital Twins) to create more efficient production processes for Teva's biopharmaceutical therapeutics.

- Type: Partnership
- Announced: 2019-02-21
- Status: completed
- Products: biopharmaceutical therapeutics, monoclonal antibodies
- Sectors: [Industrial Machinery](https://endata.com/sectors/industrial-machinery.md)

## Companies

- [Teva Pharmaceutical Industries](https://endata.com/companies/26843.md) (partner)
- [Insilico Biotechnology](https://endata.com/companies/37495.md) (partner)

## Sources

- [pharmtech.com](https://www.pharmtech.com/view/teva-insilico-partner-predictive-biomanufacturing-technology-0), 2019-02-21: "Teva will apply Insilico’s technology for predictive biomanufacturing to create more efficient biomanufacturing processes."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.